| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.004 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.15 | 0.005 |